MGX
Price
$3.05
Change
-$0.28 (-8.41%)
Updated
Oct 17 closing price
Capitalization
114.48M
24 days until earnings call
PCSA
Price
$0.31
Change
-$0.05 (-13.89%)
Updated
Oct 17 closing price
Capitalization
17.08M
Interact to see
Advertisement

MGX vs PCSA

Header iconMGX vs PCSA Comparison
Open Charts MGX vs PCSABanner chart's image
Metagenomi
Price$3.05
Change-$0.28 (-8.41%)
Volume$881.73K
Capitalization114.48M
Processa Pharmaceuticals
Price$0.31
Change-$0.05 (-13.89%)
Volume$6.07M
Capitalization17.08M
MGX vs PCSA Comparison Chart in %
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGX vs. PCSA commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGX is a Hold and PCSA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (MGX: $3.05 vs. PCSA: $0.31)
Brand notoriety: MGX and PCSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGX: 137% vs. PCSA: 51%
Market capitalization -- MGX: $114.48M vs. PCSA: $17.08M
MGX [@Biotechnology] is valued at $114.48M. PCSA’s [@Biotechnology] market capitalization is $17.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGX’s FA Score shows that 1 FA rating(s) are green whilePCSA’s FA Score has 1 green FA rating(s).

  • MGX’s FA Score: 1 green, 4 red.
  • PCSA’s FA Score: 1 green, 4 red.
According to our system of comparison, both MGX and PCSA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGX’s TA Score shows that 5 TA indicator(s) are bullish while PCSA’s TA Score has 6 bullish TA indicator(s).

  • MGX’s TA Score: 5 bullish, 4 bearish.
  • PCSA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PCSA is a better buy in the short-term than MGX.

Price Growth

MGX (@Biotechnology) experienced а +6.64% price change this week, while PCSA (@Biotechnology) price change was -19.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

MGX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGX($114M) has a higher market cap than PCSA($17.1M). MGX YTD gains are higher at: -15.512 vs. PCSA (-65.377). PCSA has higher annual earnings (EBITDA): -12.96M vs. MGX (-86.3M). MGX has more cash in the bank: 205M vs. PCSA (6.94M). PCSA has less debt than MGX: PCSA (25.6K) vs MGX (43M). MGX has higher revenues than PCSA: MGX (33.8M) vs PCSA (0).
MGXPCSAMGX / PCSA
Capitalization114M17.1M667%
EBITDA-86.3M-12.96M666%
Gain YTD-15.512-65.37724%
P/E RatioN/AN/A-
Revenue33.8M0-
Total Cash205M6.94M2,955%
Total Debt43M25.6K167,969%
TECHNICAL ANALYSIS
Technical Analysis
MGXPCSA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EMBVF9.770.07
+0.77%
Arca Continental SAB de CV
AOCIF21.64N/A
N/A
Autocanada Inc
MLLNF6.40N/A
N/A
Malin Corp PLC
SPTJF0.17N/A
N/A
Sinopec Shanghai Petrochemical Co. Ltd.
NEVIF0.05-0.01
-10.71%
Nevis Brands Inc.

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with KOD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
-8.41%
KOD - MGX
42%
Loosely correlated
-5.50%
APLM - MGX
37%
Loosely correlated
+14.60%
SABS - MGX
36%
Loosely correlated
+15.67%
BEAM - MGX
35%
Loosely correlated
+0.74%
KYTX - MGX
34%
Loosely correlated
-5.42%
More

PCSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with INO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
-15.02%
INO - PCSA
38%
Loosely correlated
-4.47%
ONCO - PCSA
35%
Loosely correlated
-2.59%
MGX - PCSA
29%
Poorly correlated
-8.41%
ACXP - PCSA
28%
Poorly correlated
-3.27%
EDIT - PCSA
28%
Poorly correlated
-4.80%
More